GHRP-6 (10mg)
All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether it’s a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
99% PURITY GUARANTEE
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC). Full analytical reports are available in the Certificate of Analysis section.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
This product is intended for research use only. It is not for human or veterinary use, not for diagnostic or therapeutic purposes, and should only be handled by qualified professionals.
Strength: 10 mg
CAS: 87616-84-0
Chemical Formula: C₄₆H₅₆N₁₂O₆
Molecular weight: 873.03 g/mol
Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Synonyms: GHRP6, Growth Hormone Releasing Peptide-6
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
GHRP 6 (Growth Hormone Releasing Peptide 6) is a synthetic hexapeptide studied for its interaction with the ghrelin receptor (GHS R1a). In laboratory settings, it is used to explore growth hormone signaling pathways, appetite regulation mechanisms, and metabolic modulation, and to evaluate pulsatile hormone release and peptide–receptor binding dynamics in endocrine and metabolic research models. For laboratory research use only; not for human or veterinary use.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1–2 business days.
-
Delivery timelines vary by destination and shipping method — view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSS–compliant system to ensure your data is fully protected.
Why Choose NOVERA COMPOUNDS Peptides?
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
INFORMATION
What is GHRP-6 (10 mg)?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide widely used in laboratory research focused on endocrine and receptor-mediated signaling. Structurally, it consists of six amino acids (His–D-Trp–Ala–Trp–D-Phe–Lys–NH₂), engineered to interact with the growth hormone secretagogue receptor (GHSR-1a), a receptor also associated with ghrelin-mediated pathways.
In controlled experimental settings, GHRP-6 is studied for its ability to stimulate growth hormone–related signaling cascades and to model peptide-driven receptor activation. Due to its relatively small size and defined structure, it is frequently used in receptor-binding assays, intracellular signaling studies, and comparative peptide research.
This compound is strictly for laboratory and preclinical research use.
Product Specifications
- CAS Number: 87616-84-0
- Peptide Sequence: His–D-Trp–Ala–Trp–D-Phe–Lys–NH₂
- Molecular Formula: C₄₆H₅₆N₁₂O₆
- Molecular weight: 873.03 g/mol
- Purity: ≥95% (HPLC and MS verified)
- Packaging Format: 10 mg lyophilized powder in sealed research-grade vial
- Storage Conditions: Store at −20 °C; protect from light and moisture
- Intended Use: For Laboratory Research Use Only
Key Characteristics of GHRP-6 (10 mg)
- Synthetic hexapeptide designed for controlled research applications
- Investigated for interaction with growth hormone secretagogue receptors (GHSR)
- Frequently used in endocrine and metabolic signaling research models
- Lyophilized powder presentation enhances stability and shelf life
- Identity and purity verified through analytical techniques such as HPLC and mass spectrometry
- Suitable for receptor-binding assays and signaling pathway evaluation
- Requires cold-chain storage and standard peptide-handling protocols
How GHRP-6 (10 mg) Supports Research
In laboratory studies, GHRP-6 serves as a model peptide for examining receptor-mediated hormone signaling. Researchers use it to evaluate how peptide ligands interact with GHSR-1a receptors and how such interactions influence downstream intracellular pathways, including calcium mobilization and hormone release patterns in experimental systems.
Because GHRP-6 is also linked to ghrelin-related pathways, it is utilized in studies exploring appetite signaling, metabolic regulation, and neuroendocrine coordination. Its short peptide length allows for controlled observation of binding affinity, signal amplification, and receptor selectivity under defined laboratory conditions. All findings remain investigational and are confined to preclinical or in vitro research environments.
Research Applications & Usage Information
GHRP-6 (10 mg) is commonly incorporated into laboratory research involving:
- Growth hormone secretion modeling
- Peptide–receptor interaction analysis
- Ghrelin receptor signaling studies
- Endocrine pathway mapping
- Pituitary function research models
- Comparative analysis of growth hormone secretagogues
- Metabolic and appetite-related signaling research
All applications are strictly limited to controlled research settings and are not intended for therapeutic use.
Handling and Storage Recommendations
To preserve structural integrity and maintain research reliability:
- Store unopened vials at −20 °C for long-term stability
- Protect from direct light, heat exposure, and humidity
- Allow vial to reach room temperature before reconstitution to prevent moisture condensation
- After reconstitution, store solutions at 2–8 °C and use within laboratory-defined timelines
- Avoid repeated freeze–thaw cycles to preserve peptide integrity
- Follow institutional safety and peptide-handling guidelines
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Fairhall KM, Mynett A, Robinson IC. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol. 1995;144(3):555-560. doi:10.1677/joe.0.1440555
- Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J Endocrinol. 1996;148(2):197-205. doi:10.1677/joe.0.1480197
- Dickson SL, Viltart O, Bailey AR, Leng G. Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology. 1997;66(3):188-194. doi:10.1159/000127237
What is GHRP-6 (10 mg)?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide widely used in laboratory research focused on endocrine and receptor-mediated signaling. Structurally, it consists of six amino acids (His–D-Trp–Ala–Trp–D-Phe–Lys–NH₂), engineered to interact with the growth hormone secretagogue receptor (GHSR-1a), a receptor also associated with ghrelin-mediated pathways.
In controlled experimental settings, GHRP-6 is studied for its ability to stimulate growth hormone–related signaling cascades and to model peptide-driven receptor activation. Due to its relatively small size and defined structure, it is frequently used in receptor-binding assays, intracellular signaling studies, and comparative peptide research.
This compound is strictly for laboratory and preclinical research use.
Product Specifications
- CAS Number: 87616-84-0
- Peptide Sequence: His–D-Trp–Ala–Trp–D-Phe–Lys–NH₂
- Molecular Formula: C₄₆H₅₆N₁₂O₆
- Molecular weight: 873.03 g/mol
- Purity: ≥95% (HPLC and MS verified)
- Packaging Format: 10 mg lyophilized powder in sealed research-grade vial
- Storage Conditions: Store at −20 °C; protect from light and moisture
- Intended Use: For Laboratory Research Use Only
Key Characteristics of GHRP-6 (10 mg)
- Synthetic hexapeptide designed for controlled research applications
- Investigated for interaction with growth hormone secretagogue receptors (GHSR)
- Frequently used in endocrine and metabolic signaling research models
- Lyophilized powder presentation enhances stability and shelf life
- Identity and purity verified through analytical techniques such as HPLC and mass spectrometry
- Suitable for receptor-binding assays and signaling pathway evaluation
- Requires cold-chain storage and standard peptide-handling protocols
How GHRP-6 (10 mg) Supports Research
In laboratory studies, GHRP-6 serves as a model peptide for examining receptor-mediated hormone signaling. Researchers use it to evaluate how peptide ligands interact with GHSR-1a receptors and how such interactions influence downstream intracellular pathways, including calcium mobilization and hormone release patterns in experimental systems.
Because GHRP-6 is also linked to ghrelin-related pathways, it is utilized in studies exploring appetite signaling, metabolic regulation, and neuroendocrine coordination. Its short peptide length allows for controlled observation of binding affinity, signal amplification, and receptor selectivity under defined laboratory conditions. All findings remain investigational and are confined to preclinical or in vitro research environments.
Research Applications & Usage Information
GHRP-6 (10 mg) is commonly incorporated into laboratory research involving:
- Growth hormone secretion modeling
- Peptide–receptor interaction analysis
- Ghrelin receptor signaling studies
- Endocrine pathway mapping
- Pituitary function research models
- Comparative analysis of growth hormone secretagogues
- Metabolic and appetite-related signaling research
All applications are strictly limited to controlled research settings and are not intended for therapeutic use.
Handling and Storage Recommendations
To preserve structural integrity and maintain research reliability:
- Store unopened vials at −20 °C for long-term stability
- Protect from direct light, heat exposure, and humidity
- Allow vial to reach room temperature before reconstitution to prevent moisture condensation
- After reconstitution, store solutions at 2–8 °C and use within laboratory-defined timelines
- Avoid repeated freeze–thaw cycles to preserve peptide integrity
- Follow institutional safety and peptide-handling guidelines
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Fairhall KM, Mynett A, Robinson IC. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol. 1995;144(3):555-560. doi:10.1677/joe.0.1440555
- Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J Endocrinol. 1996;148(2):197-205. doi:10.1677/joe.0.1480197
- Dickson SL, Viltart O, Bailey AR, Leng G. Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology. 1997;66(3):188-194. doi:10.1159/000127237




